StonvexLoading…
StonvexStonvexStonvexCore line items from ARE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $671.02M | $3.03B | $2.27B | $1.52B |
Operating Income | Not available | Not available | Not available | Not available |
Net Income | $361.65M | $-1.43B | $-348.69M | $-115.94M |
EPS (Diluted) | $2.10 | $-8.44 | $-2.09 | $-0.71 |
Total Assets | $34.17B | $34.08B | $37.38B | $37.62B |
Total Liabilities | $14.80B | $14.93B | $16.26B | $15.88B |
Cash & Equivalents | $418.72M | $549.06M | $579.47M | $520.54M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 170.87M | 170.54M | 170.28M | 170.33M |